GEMCITABINE GLENMARK 200MG VIAL 200 Powder for injection 10ml Vial

Product Description

Gemcitabine Glenmark 200mg Powder for injection is a vital chemotherapy medication used in the treatment of various types of cancer.
It is an antimetabolite that works by interfering with the growth of cancer cells, which are then destroyed by the body.
This medication is exclusively administered by qualified healthcare professionals in a clinical setting.

Benefits of Use

• Effective in treating a range of solid tumors, including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer.
• Part of standard treatment regimens, often in combination with other chemotherapeutic agents or radiation therapy.
• A crucial option for managing certain advanced or metastatic cancers to improve patient outcomes and quality of life.

How to Use

1. Gemcitabine Glenmark 200mg Powder for injection must be prepared and administered by a healthcare professional experienced in the use of antineoplastic agents.
2. The powder is first reconstituted with an appropriate sterile diluent, typically 0.9% sodium chloride solution.
3. The reconstituted solution is then further diluted to the desired concentration for intravenous infusion.
4. It is administered as an intravenous infusion over approximately 30 minutes.
5. The dosage and administration schedule are determined by the treating oncologist based on the specific type of cancer, the patient’s body surface area, overall health, and response to treatment.
6. Patients should not attempt to self-administer this medication.

Caution & Warnings

• Gemcitabine Glenmark is a potent chemotherapy agent and should only be administered under the supervision of a physician qualified in the use of antineoplastic therapy.
• Regular monitoring of blood counts (complete blood count) is essential during treatment due to the risk of bone marrow suppression (myelosuppression), including neutropenia, thrombocytopenia, and anemia.
• Close monitoring of liver and kidney function tests is required as gemcitabine can cause hepatic and renal toxicity.
• Patients should be monitored for signs of pulmonary toxicity, including dyspnea and interstitial pneumonitis.
• Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding, as gemcitabine can cause harm to the fetus or infant.
• Avoid contact with skin and mucous membranes during preparation and administration.
• Report any unusual side effects or adverse reactions immediately to your healthcare provider.
• Keep out of reach of children.

Ingredients

Active Ingredient: Gemcitabine Hydrochloride equivalent to 200 mg Gemcitabine.
Excipients: Sodium hydroxide (for pH adjustment), hydrochloric acid (for pH adjustment).

Product Details

• Form: Powder for injection
• Strength: 200 mg per vial
• Package Size: 10 ml Vial
• Manufacturer: Glenmark Pharmaceuticals
• Drug Type: Prescription Only Medicine (POM)